Suppl. 2: Cell cycle analysis of GEP-NEN cell lines untreated and treated with siomycin A: BON (A), KRJ-1 (B)
, QGP-1 (C), were treated with siomycin A versus DMSO for 96h. Cells were fixed and stained with an antiphospho-H3 antibody and propidium iodide. All phases of the cell cycle and the cell death-associated sub-G1 phase were indicated. Data of one representative experiment is shown (Average data can be found in Fig. 6 ): After 96h the majority of treated BON cells (70.2% versus 0.71% in DMSO control) has accumulated in Sub-G1 population and mitoses have reduced to 0.1% (versus 1.26% in DMSO control) of counted cells (A). In treated KRJ-1 cell culture, the sub-G1 population has tripled (26.6% versus 9.24% of DMSO control). Cells in mitosis phase of the cell cycle have dwindled to 0.084% within the siomycin A treated cells compared to 0.45% in the DMSO group after 96h (B). QGP-1 cells showed a 10-fold increase (18.0% versus 1.77% in DMSO control) of the sub-G1 population after 96h, and a decrease of mitotic cells from 1.08% in DMSO to 0.078 in the siomycin A treated population (C). Following 96h of treatment, in LCC-18 cells mitoses have diminished from 1.12% in the DMSO control to 0.085% under siomycin A and the sub-G1 population has increased 6-fold to 55.3% (versus 9.21% in DMSO control; D). 
